When is a hyperope actually a myope? This case presents an aphakic patient with Marfan syndrome and an extremely long axial length, who needs to be managed like a high myope. This post also discusses a variety of pharmacological approaches to myopia management, based on a fascinating case presented in the subsequent Facebook discussion.
Can body height compared to axial length be used to predict risk of myopia or high myopia? This longitudinal study examined body height, axial length and refraction – growth mechanisms are likely linked in emmetropes but not in myopes.
Pathologic myopia is one of the major causes of blindness worldwide. Degenerative changes associated with high myopia, including posterior staphyloma formation and scleral thinning, are caused by the progressive elongation of globe axial length and stretching of the sclera, choroid and retina. The aim of this meta-analysis was to investigate and quantitatively define the efficacy of PSR in controlling axial elongation and refraction progression.
Being able to assess myopia progression in a similar way to height and weight using growth curves is beneficial for both practitioners and patients as it provides a comparison against a calculated average, helping to predict future high myopes and track progression and control outcomes. How to growth charts from European and Asian studies compare? We explore the comparisons, advantages and disadvantages of using growth charts for axial length in myopia.
Half of children with high myopia have an underlying systemic condition: ophthalmology co-management, best optical corrections, parental education and eye health monitoring are crucial. It’s also important to offer myopia control strategies while also being aware of the limitations of the evidence base. This blog provides guidance on appropriate ocular health and optical management of children with more than 5-6D of myopia.
Using cross-sectional data collected from European population-based studies the authors establish an association between increasing myopia and risk of vision impairment in later life.
Usually myopia and axial length are correlated. What does it mean when your patient has low myopia and high axial length? This case discusses various correlations between ocular and individual parameters and axial length.
How frequently should we measure axial length in myopia management practice, and how should it best direct our treatment strategy? Here we discuss how axial length change is related to refraction and ethnicity, and how to determine whether an axial length change is normal due to emmetropization or indicating myopia progression.
This review covers how well axial length relates to refraction and predicting future myopia, how to measure axial length, its value in orthokeratology and atropine management, how axial length influences a treatment plan and can you practice myopia management without it.
The research information on using atropine for myopia control is evolving. Previous research indicated 0.01% atropine was best, but newer research says otherwise. In this clinical case, practitioners discuss treatment strategies, which are put in research context with clinical pearls for practice.
